GleamWall
中文EN

MDXG MIMEDX GROUP, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1376339 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-22.8%
TTM net income YoY-147.0%
TTM EPS YoY-148.1%
Revenue 3-yr CAGR-0.6%
Net income 3-yr CAGR—

Margins

Gross margin77.3%
Operating margin-8.3%
Net margin-6.3%
FCF margin—
EBITDA margin-3.5%

Returns

ROE-8.5%
ROA-6.6%
ROIC (approx.)-19.3%
Asset turnover1.04x

Leverage & solvency

Liabilities / assets20.2%
Debt / equity0.00x
Current ratio4.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.08x
Accruals ratio-13.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$62.28M$64.36M$58.99M$118.09M$113.72M$98.61M$88.20M$92.91M
Cost of revenue$12.58M$19.98M$17.37M$19.05M$18.72M$18.68M$16.56M$16.91M
Gross profit$49.70M$44.38M$41.62M$99.04M$95.01M$79.92M$71.65M$76.00M
R&D expense$2.80M$2.78M$4.14M$4.76M$3.70M$3.30M$3.33M$3.57M
SG&A expense$58.31M$59.78M$53.23M$73.07M$69.00M$64.15M$59.97M$61.04M
Operating income-$11.70M-$18.47M-$16.05M$21.08M$22.19M$12.37M$8.25M$11.05M
Interest expense——$402,000$405,000$425,000$475,000$478,000$521,000
Pretax income-$11.06M-$17.78M-$15.33M$21.80M$22.85M$13.01M$8.61M$11.25M
Income tax-$2.38M-$2.94M-$4.47M$6.60M$6.10M$3.39M$1.59M$3.81M
Net income-$8.68M-$14.84M-$10.86M$15.19M$16.75M$9.62M$7.02M$7.44M
EBITDA-$11.33M-$18.02M-$15.52M$34.27M$22.76M$12.93M$8.81M$11.62M
EPS (basic)-0.06-0.10-0.07—0.110.070.05—
EPS (diluted)-0.06-0.10-0.07—0.110.060.05—
Weighted avg. shares (diluted)145.87M147.80M148.45M—149.71M149.32M149.68M—
Balance sheet
Cash & equivalents$120.79M$135.84M$159.77M$166.12M$142.08M$118.87M$106.43M$104.42M
Receivables$37.27M$41.30M$46.03M$75.71M$78.19M$69.23M$62.29M$55.83M
Inventory$22.09M$20.93M$26.23M$25.34M$26.50M$24.89M$24.07M$23.81M
Current assets$187.23M$205.37M$240.33M$277.47M$254.09M$220.88M$200.11M$191.89M
PP&E, net$4.71M$4.91M$4.76M$4.71M$5.00M$5.39M$5.77M$5.94M
Goodwill$19.44M$19.44M$19.44M$19.44M$19.44M$19.44M$19.44M$19.44M
Intangibles$11.12M$12.09M$13.14M$14.16M$11.15M$12.03M$11.06M$11.63M
Total assets$264.55M$281.00M$308.68M$342.65M$318.99M$291.11M$270.42M$263.92M
Current liabilities$43.03M$38.50M$44.55M$64.27M$57.68M$50.29M$42.62M$45.59M
Short-term debt$0$1.50M$1.50M$1.50M$1.38M$1.25M$1.12M$1.00M
Long-term debt$0$15.71M$16.09M$16.47M$16.84M$17.21M$17.53M$17.83M
Total debt$0$17.21M$17.59M$17.97M$18.21M$18.46M$18.66M$18.83M
Total liabilities$53.47M$65.00M$65.74M$86.11M$80.04M$74.48M$67.64M$70.81M
Shareholders' equity$211.08M$216.00M$242.94M$256.55M$238.95M$216.62M$202.78M$193.11M
Net debt-$120.79M-$118.63M-$142.18M-$148.15M-$123.87M-$100.41M-$87.77M-$85.59M
Shares outstanding145.93M145.72M148.93M148.09M148.08M147.92M147.61M146.93M
Cash flow statement
Operating cash flow$3.92M-$10.02M$1.88M$24.96M$29.33M$14.42M$5.30M$18.78M
Investing cash flow-$193,000-$635,000-$5.64M-$335,000-$5.26M-$887,000-$406,000-$2.77M
Financing cash flow-$18.77M-$13.28M-$2.58M-$583,000-$857,000-$1.09M-$2.88M-$400,000
Depreciation & amortization$370,000$441,000$528,000$13.19M$572,000$558,000$558,000$564,000
Stock-based compensation$3.21M$903,000-$1.70M$2.46M$4.92M$4.75M$4.26M$4.69M
Share buybacks$304,000——$0$0———

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.